Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chung Shan Medical University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| three surgical methods in Laparotomy, Laparoscope, and da Vinci | no intervention |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| operative time | The duration of the operation | From entry into the operating room for anesthesia induction to completion of skin closure at the end of surgery (Day 1, intraoperative period), assessed over an estimated duration of up to 10 hours |
| bleeding | The amount of intraoperative bleeding | From initiation of surgery (skin incision) to completion of wound closure during surgery (Day 1, intraoperative period), assessed over an estimated duration of up to 10 hours. |
| Measure | Description | Time Frame |
|---|---|---|
| hospital stay | The postoperative recovery time | From the date of surgery to the date of hospital discharge, assessed up to 55 days postoperatively |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
A population that needs robotic surgery for gastrectomy, liver resection, or pancreatectomy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Cheng-Ming Peng, MD, Ph.D. | Department of Surgery, da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chung Shan Medical University Hospital | Taichung | 40201 | Taiwan |
Individual participant data (IPD) will not be shared due to privacy concerns and institutional policies that restrict the disclosure of patient-level data, even in de-identified form. Additionally, there is currently no plan or infrastructure in place for secure data sharing in accordance with applicable ethical and legal standards.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013274 | Stomach Neoplasms |
| D010190 | Pancreatic Neoplasms |
| D008113 | Liver Neoplasms |
| D018281 | Cholangiocarcinoma |
| D050500 | Pancreatitis, Chronic |
| D010181 | Pancreatic Cyst |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| D004066 |
| Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
| D004701 | Endocrine Gland Neoplasms |
| D010182 | Pancreatic Diseases |
| D004700 | Endocrine System Diseases |
| D008107 | Liver Diseases |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
| D010195 | Pancreatitis |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D003560 | Cysts |